Fenwick has advised Formation Bio on the deal. Formation Bio, an AI-native drug development company, has entered into a licensing agreement with Sanofi, a French multinational...
Formation Bio Enters Licensing Agreement with Sanofi for Gusacitinib
Formation Bio’s $372 Million Series D Financing Round
Fenwick & West represented Formation Bio in the transaction, and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Thrive Capital. Formation Bio, a NYC-based tech-driven and...


























